EP Permed JTC2024 Booklet
EP PerMeds Joint Transnational Call for Proposals 2024 (JTC2024) marks a significant step in aligning strategies and advancing collaborative research efforts in the field of personalised medicine between different countries and European national regions. Aiming to foster innovation and reinforce the competitiveness of European research, the call brought together 38 funding organisations from 23 countries and 10 regions.
The JTC2024 received an impressive response from the research community, with 283 eligible pre-proposals submitted. Following a competitive selection process, 64 consortia were invited to submit full proposals, and 27 outstanding projects were selected for funding, representing a total investment of 39.2 million Euros.
EP Permed Workshop on Scientific Integrity
EP PerMed hosted a Workshop on Scientific Integrity as a satellite event of the EP PerMed Conference on Personalised Medicine Research on 12 and 13 February 2025 in Berlin (Germany). The workshop was mainly designed for the scientific community in personalised medicine applying to EP PerMed funding or other funding opportunities.
Framed in the EP PerMed strategy to support the research community on Ethical Legal and Social Aspects (ELSA) of personalised medicine, this training action explored critical issues related to scientific integrity in personalised medicine related research.
EP PerMed Conference on Personalised Medicine Research
EP PerMed organised a conference on personalised medicine research on 11 and 12 February 2025 in Berlin, Germany. The conference brought together around 250 international experts in the areas of personalised medicine to present and discuss cutting-edge research and their successful translation into clinical practice.
The two-day conference combined insights into cutting-edge transnational research from different perspectives such as diagnostics, therapy and clinical trials, and addressed ethical and legal aspects of personalised medicine. It also provided an excellent networking opportunity for top researchers from Europe and beyond to collaborate on future challenges in personalised medicine and prepare for upcoming funding opportunities.
EP Permed first In-situ Visit
EP PerMed held the first in a series of in-situ visits in Stockholm, Sweden on 11-12 November.
The EP PerMed in-situ visits to selected personalised medicine centres aim specifically to provide real-life examples of successful personalised medicine research, innovation and implementation in healthcare systems, and to inform the EP PerMed stakeholder community about ongoing activities in EU Member States.
Genomic Medicine Sweden (GMS) is a national infrastructure for the implementation of precision medicine across the country, which was launched in 2018. Since then, the initiative has expanded and regional precision medicine centres are being established, of which GMS is a central component.
EP Permed ELSA Symposium
The EP PerMed Symposium on Ethical, Legal and Social Aspects of Personalised Medicine addressed the main ethical challenges in personalised medicine research in order to raise awareness and train researchers by addressing ELSA issues in personalised medicine from a macro approach (ethics of new technologies) to a specific approach (ethics, legal issues, privacy issues and artificial intelligence (AI) in personalised medicine).
The event took place in a hybrid format with around 120 participants on site and online on 26 September 2024 in Brussels, Belgium.
EP Permed first Round Table
EP PerMed organised a roundtable discussion on ‘De-risking Innovation in Personalised Medicine’ on 27 May 2024 in Brussels. The event accompanied the Belgian Presidency of the EU and aimed to shape the future of healthcare in the Benelux region and beyond.
Our round table on Personalised Medicine promised to spark important conversations, drive innovation and foster collaboration towards a healthcare landscape that is personalised. We invited professionals who are passionate about advancing healthcare to register now and be part of this transformative journey.
The event was organised by EP PerMed Partner EIT Health and was open to industry leaders, clinicians, healthcare providers, patient advocates, policy makers, government agencies, data specialists, researchers and academics.